399
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Chronic Mucocutaneous Candidiasis: A Case Report

, & ORCID Icon
Pages 231-236 | Received 16 Nov 2022, Accepted 12 Jan 2023, Published online: 25 Jan 2023

Figures & data

Table 1 Blood Laboratory Examinations of the Patient for Diagnosis

Table 2 Blood Laboratory Examinations of the Patient for Diagnosis

Figure 1 Clinical manifestations of CMC. (A) Facial lesions before treatment, with visible red plaques covered with thick brown scabs. (B) After 1 month of itraconazole treatment, the thick scabs had disappeared, and the plaque area was reduced and flattened.

Figure 1 Clinical manifestations of CMC. (A) Facial lesions before treatment, with visible red plaques covered with thick brown scabs. (B) After 1 month of itraconazole treatment, the thick scabs had disappeared, and the plaque area was reduced and flattened.

Figure 2 Microbiological examination of CMC. (A) CHROMagar chromogenic medium showed green colonies, which were uplifted, moist, smooth, and pearly. (B) The drug sensitivity test identified sensitivity to itraconazole, nystatin, and 5-fluorocytosine and moderate sensitivity to terbinafine.

Figure 2 Microbiological examination of CMC. (A) CHROMagar chromogenic medium showed green colonies, which were uplifted, moist, smooth, and pearly. (B) The drug sensitivity test identified sensitivity to itraconazole, nystatin, and 5-fluorocytosine and moderate sensitivity to terbinafine.